Mednax Inc Stock
Mednax Inc Stock
The Mednax Inc stock is trending slightly upwards today, with an increase of €0.10 (0.550%) compared to yesterday's price.
Currently there is a rather positive sentiment for Mednax Inc with 3 Buy predictions and 0 Sell predictions.
On the other hand, the target price of 17 € is below the current price of 18.2 € for Mednax Inc, so the potential is actually -6.59%.
Our community identified positive and negative aspects for Mednax Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Mednax Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Mednax Inc in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | 0.550% | 1.685% | 7.738% | 52.101% | -1.630% | 32.117% | -14.623% |
| Chemed Corp. | 0.000% | -0.610% | -4.678% | -37.308% | -10.440% | - | - |
| Select Medical Holdings | 1.470% | -1.449% | -0.730% | -2.857% | 8.800% | -46.457% | -53.103% |
| Davita Inc. | -0.540% | 1.386% | -4.335% | -6.672% | 32.725% | 64.863% | 42.698% |
Comments
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) had its price target raised by analysts at Macquarie from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MD provided by MarketBeat